Symbol
ELVN on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership
3.23M shares
Security Ownership
5.4%

Venrock Healthcare Capital Partners III, L.P. ownership in Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN)

2025-11-14 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.23M shares of Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN). This represents 5.4% percent ownership of the company.